If we don't have a deal by June there will be a lot of disillusioned shareholders. To say the stock would trade significantly sub $0.50 is an understatement. You can only lead the "herd" on for so long.
"Javelin, which is developing drugs for pain management, said it is raising the money to place it in a more attractive position as it proceeds in ongoing partnership discussions."
Market Data 
Markets 
AI
